PROMOTING

HEALTHY AGING

with senolytic therapies

for age-related diseases

IAAC-BASED SENOLYTICS

Chronic Kidney Disease     Renal Transplants
Liver Fibrosis     Pulmonary Fibrosis
Neurodegenerative Diseases     Frailty

Sarcopenia     Osteoarthritis

mRNA-BASED SENOLYTICS

Miscellaneous

Challenges: World population of 65+ is expected to double from 740 M (2020) to 1.6 B (2050)
~80 % of 65+ population suffers from at least one chronic condition

Get in Touch…

Science | Publications | Press

Lead compound RFB01016 extends health and life span, improves neuromuscular function and reduces senescent cells in several tissues (kidney, liver, brain, spleen, fat, ...).

frailty-index-uncensored_web
Days-of-survival-male_web
Hanging-wire-impulse-week-8_web-4

Epilipidomics of Senescent Dermal Fibroblasts Identify Lysophosphatidylcholines as Pleiotropic Senescence-Associated Secretory Phenotype (SASP) Factors

Startup Report

Longevity Senotherapeutics Report

Wie man mit 80 den Körper eines 30-Jährigen haben kann

Supported by:
Austria-Wirtschaftsservice-Logo-1

HEALTHY AGING

office@rockfishbio.com

Rockfish Bio AG

Reichsratsstrasse 15/15
1010 Wien
Austria

FN 569591 i, HG Wien
UID/VAT: ATU77556949

Logo-RockfishBio